(Q33398141)

English

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

0 references

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

Fernando A. Soares

object named as

Fernando A Soares

5

0 references

José Humberto Tavares Guerreiro Fregnani

3

object named as

José H T G Fregnani

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Yukie Sato-Kuwabara

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

José I Neves

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rubens A Sallum

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

7 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

7 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

describes a project that uses

fluorescence in situ hybridization

1 reference

based on heuristic

inferred from title

Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

HER-2 (c-erbB-2) test update: present status and problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

The ErbB/HER receptor protein-tyrosine kinases and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Signal events: Cell signal transduction and its inhibition in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Herceptin (trastuzamab) in advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

21 June 2018

Population attributable risks of esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-6

21 January 2018

Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-6

21 January 2018

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-6

21 January 2018

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-6

21 January 2018

Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-6

21 January 2018

Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2648997

31 October 2018

Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Risk factors related to esophageal cancer in Rio Grande do Sul, Brazil]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19128465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-9-6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33398141&oldid=2195322267"